Back to RPRX overview

RPRX Royalty Pharma PE ratio, current and historical analysis

The price-to-earnings ratio for Royalty Pharma stock stands at 12.22 as of Feb 23, 2024. This is based on the current EPS of $2.54 and the stock price of $31.03 per share. A decrease of 74% has been recorded in the PE ratio compared to the average of 46.3 of the last four quarters.

RPRX PE ratio history

How has RPRX's PE ratio performed in the past

Over the last four years, the average PE ratio of Royalty Pharma has been 55.04. The current 12.22 P/E ratio is 78% lower than the historical average. In the past four years, RPRX's PE ratio peaked in the Dec 2022 quarter at 395.2, with a price of $39.52 and an EPS of $0.1. The Sep 2020 quarter marked the lowest point at 7, with a price of $42.07 and an EPS of N/A.

Average
55.04
Median
29.08
Minimum
7
Maximum
395.2

Royalty Pharma PE ratio by year

Maximum annual increase: 1,377.94% in 2022

Maximum annual decrease: -97.2% in 2023

Year PE ratio Change
2023 11.06 -97.2%
2022 395.2 1,377.94%
2021 26.74 -29.48%
2020 37.92 N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A

RPRX average PE ratio chart

What is the average PE ratio of RPRX for the past years

Currently, RPRX's PE ratio is lower than the 3-year average.

3-year avg
64.44
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

RPRX PE vs peers

What is RPRX's PE ratio compared to its peers

RPRX's PE ratio stands lower than its peer stocks LLY and ABT.

Stock name PE ratio Market cap
RPRX Royalty Pharma plc 12.32 $18.69B
ABT Abbott Laboratories 36.12 $205.59B
ANIP Ani Pharmaceuticals Inc 114.46 $1.24B
LLY ELI LILLY & Co 132.64 $733.48B

Frequently asked questions

What is Royalty Pharma's PE ratio?

The price to earnings ratio for RPRX stock as of Feb 23, 2024, stands at 12.22.

What is the 3-year average PE ratio for Royalty Pharma (RPRX)?

The 3-year average price to earnings ratio for RPRX stock is 64.44.

What is the highest PE ratio for RPRX?

The highest quarterly PE ratio in the last four years has been 395.2 and it was in the Dec 2022 quarter.

How does the current PE ratio for RPRX compare to its historical average?

RPRX's current price to earnings ratio is 78% below its 4-year historical average.

How is RPRX's PE ratio calculated (Royalty Pharma PE ratio formula)?

The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Feb 23, 2024), Royalty Pharma's stock price is $31.03. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $2.54. Therefore, Royalty Pharma's PE ratio for today is 12.22. PE RATIO(12.22) = STOCK PRICE($31.03) / TTM EPS($2.54)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.